Evaluation of the Charlson Comorbidity Index to Predict Early Mortality in Implantable Cardioverter Defibrillator Patients

Abstract

Noncardiac conditions are commonly observed among patients undergoing ICD implantation. Guidelines must incorporate a comprehensive assessment of concomitant comorbidities to minimize the risk of EM and to maximize the survival benefit with ICD therapy.